RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 DURING ANTIBIOTIC KILLING OF ESCHERICHIA-COLI IN WHOLE-BLOOD - INFLUENCE OF ANTIBIOTIC CLASS, ANTIBIOTIC CONCENTRATION, AND PRESENCE OF SEPTIC SERUM

被引:92
作者
PRINS, JM
KUIJPER, EJ
MEVISSEN, MLCM
SPEELMAN, P
VANDEVENTER, SJH
机构
[1] ACAD MED CTR, DEPT MED MICROBIOL, 1105 AZ AMSTERDAM, NETHERLANDS
[2] ACAD MED CTR, CTR HEMOSTASIS THROMBOSIS ATHEROSCLEROSIS & INFLA, 1105 AZ AMSTERDAM, NETHERLANDS
关键词
D O I
10.1128/IAI.63.6.2236-2242.1995
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The concentration and accessibility of endotoxin can increase following antibiotic killing of gram-negative bacteria. There are indications that antibiotics may differ in this respect. We measured endotoxin levels in RPMI 1640 and tumor necrosis factor alpha (TNF-alpha) and interleukin-6 production in whole blood ex vivo after exposure of log-phase Escherichia coli to antibiotics belonging to different classes, in a final concentration of 0.5, 5, or 50 times the MIC. After 4 h of incubation at 50 times the MIC, ceftazidime and ciprofloxacin treatment resulted in levels of endotoxin, TNF-alpha, and interleukin-6 significantly higher than those of imipenem and gentamicin (P < 0.001). Similar differences in cytokine induction were measured after 8 h of incubation. At 0.5 times the MIG, the differences between the antibiotics in measured endotoxin and cytokine levels were small, with levels comparable to the levels in untreated cultures. Polymyxin B and, to a lesser degree, recombinant bactericidal/permeability-increasing protein 21 (rBPI-21) were found to be potent inhibitors of TNF-alpha release, supporting the concept that the differences between the antibiotics in cytokine production were indeed due to differences in amounts of biologically active endotoxin. The presence of serum from patients suffering from untreated sepsis decreased TNF-alpha production significantly, in a concentration dependent manner.
引用
收藏
页码:2236 / 2242
页数:7
相关论文
共 31 条
[1]   ANTIBIOTIC-INDUCED BACTERIAL KILLING STIMULATES TUMOR-NECROSIS-FACTOR-ALPHA RELEASE IN WHOLE-BLOOD [J].
ARDITI, M ;
KABAT, W ;
YOGEV, R .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :240-244
[2]   INHIBITION OF ENDOTOXIN REACTIVITY BY AMINOGLYCOSIDES [J].
ARTENSTEIN, AW ;
CROSS, AS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (05) :826-828
[3]   THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[4]  
BRUIN KF, 1994, ENDOTOXIN RESPONSIVE, P78
[5]  
BRUIN KF, 1994, THESIS U AMSTERDAM A, P31
[6]   INACTIVATION OF ENDOTOXIN BY POLYMYXIN-B [J].
COOPERSTOCK, MS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (04) :422-425
[7]   ANTIBIOTIC-INDUCED RELEASE OF ENDOTOXIN FROM BACTERIA IN-VITRO [J].
CROSBY, HA ;
BION, JF ;
PENN, CW ;
ELLIOTT, TSJ .
JOURNAL OF MEDICAL MICROBIOLOGY, 1994, 40 (01) :23-30
[8]   EFFECTS OF DIFFERENT TYPES AND COMBINATIONS OF ANTIMICROBIAL AGENTS ON ENDOTOXIN RELEASE FROM GRAM-NEGATIVE BACTERIA - AN INVITRO AND INVIVO STUDY [J].
DOFFERHOFF, ASM ;
NIJLAND, JH ;
DEVRIESHOSPERS, HG ;
MULDER, POM ;
WEITS, J ;
BOM, VJJ .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, 23 (06) :745-754
[9]   THE RELEASE OF ENDOTOXIN FROM ANTIBIOTIC-TREATED ESCHERICHIA-COLI AND THE PRODUCTION OF TUMOR-NECROSIS-FACTOR BY HUMAN MONOCYTES [J].
DOFFERHOFF, ASM ;
ESSELINK, MT ;
DEVRIESHOSPERS, HG ;
VONZANTEN, A ;
BOM, VJJ ;
WEITS, J ;
VELLENGA, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (03) :373-384
[10]   THE BACTERICIDAL PERMEABILITY-INCREASING PROTEIN (BPI), A POTENT ELEMENT IN HOST-DEFENSE AGAINST GRAM-NEGATIVE BACTERIA AND LIPOPOLYSACCHARIDE [J].
ELSBACH, P ;
WEISS, J .
IMMUNOBIOLOGY, 1993, 187 (3-5) :417-429